06Jun

When mom told you to eat your vegetables because they were good for you, she was on to something.

The apple and carrot sticks moms pack into lunch boxes and the other fruit and vegetables at dinner are more than just good healthy food. They help you live longer and have a lower risk of dying from heart disease and cancer.

If that all sounds familiar, it should. Medical professionals and the US Department of Agriculture have been telling us for years to eat more fruit and vegetables.

But what’s the right mix? And how much?

The rule of thumb, at least from the American Heart Association, has been 4-5 servings each of fruit and vegetables a day. Here’s an infographic showing us what a serving should be.

Now comes a new study published this month in the journal Circulation telling us there’s nothing wrong with that many servings, but the optimal amount for good health and the lowest risk of death is five servings.Total. Two servings a day of fruit and three of vegetables was found by researchers to be associated with the greatest longevity. More doesn’t hurt, but it doesn’t appreciably make a difference.

“This amount likely offers the most benefit in terms of prevention of major chronic disease and is a relatively achievable intake for the general public,” said Dong D. Wang, M.D., Sc.D., an epidemiologist, nutritionist and a member of the medical faculty at Harvard Medical School and Brigham and Women’s Hospital in Boston.

The lead author of the study, Wang went on to tell ScienceDaily that it makes a difference what the fruit and vegetables are. “We also found that not all fruits and vegetables offer the same degree of benefit, even though current dietary recommendations generally treat all types of fruits and vegetables, including starchy vegetables, fruit juices, and potatoes, the same.”

Peas and corn, as popular as the latter may be, offered no real benefit in lowering mortality. However, green leafy vegetables, nonstarchy vegetables, cruciferous vegetables, citrus fruit, vitamin C–rich, and β-carotene-rich fruit and vegetables did.

Anne Thorndike, M.D., M.P.H., chair of the American Heart Association’s nutrition committee and an associate professor of medicine at Harvard Medical School, said, “This research provides strong evidence for the lifelong benefits of eating fruits and vegetables and suggests a goal amount to consume daily for ideal health.”

Photo by Louis Hansel @shotsoflouis on Unsplash

author avatar
Green Key

Green Key Resources is Hiring!

Green Key Resources is hiring! We’re looking to hire several experienced recruiting professionals to join our growing teams at our offices across the US.

Jun 6, 2023

COVID Trials Raising Awareness of Clinical Diversity

Minority representation in clinical trials is an issue the coronavirus vaccine trials has brought out of medical publications and journals and into the broader media.

In just the last few weeks, discussions of the need to ensure Black, Hispanic, Asian and other ethnic minority participation in the trials have appeared on NPRABCCNBC and elsewhere.

“If Black people have been the victims of COVID-19, we’re going to be the key to unlocking the mystery of COVID-19,” Rev. Anthony Evans, president of the National Black Church Initiative, told the Los Angeles Times.

Recruiting minorities for clinical trials is not a new issue. Five years ago, the FDA’s Center for Drug Evaluation and Research began publishing demographic summaries of clinical trials. The reports are in response to a Congressional mandate “to report on the diversity of participants in clinical trials and the extent to which safety and effectiveness data is based on demographic factors such as sex, age, and race.”

A recent article on the pharmaceutical news site PMLive carried the headline “If our patients are diverse, why are clinical trials so white?” The article notes that, “Although 20% of the people living with multiple myeloma (cancer of plasma cells) in the US are African Americans, they only account for 6% of all patients in clinical trials.”

Clinical trial managers and researchers are making an effort to diversify their patient volunteers. Writing in Stat, Jocelyn Ashford, a patient advocate and trial recruiter, says creating an inclusive clinical trial requires engaging “the target community in discussions around the recruitment plan. By bringing these communities to the table early, we can hear their input instead of making assumptions about how to best reach them.”

In recruiting Black participants, she’s reached out to historically Black fraternities and sororities. “These organized groups of educated, social-minded individuals are looking to give back to their communities and can act as bridges to their parents, grandparents, and the Black community more broadly.”

Forbes last year suggested that a key to increasing minority representation is to make it easier for minorities to participate by designing ways to gather the data via wearables. It’s also important, says the Forbes article, that clinical trial investigators themselves be representative of different groups.

Citing a Clinical Research Pathways report on “Diversity in Clinical Trials,” Forbes observes that “patients from minority communities are more likely to enroll when they learn about studies from doctors in their own communities.”

For the earliest of the COVID trials, Moderna is getting help from Dr. Carlos del Rio, executive associate dean at the Emory University School of Medicine in Atlanta. He has a record of successfully recruiting minority trial volunteers, according to Kaiser Health News.

Said del Rios, “We’re trying to do our best to get out to the communities that are most at risk.”

Photo by Fadil Fauzi on Unsplash

[bdp_post_carousel]

author avatar
Green Key